Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutated tumor alleles are expressed according to their DNA frequency.
Castle JC, Loewer M, Boegel S, Tadmor AD, Boisguerin V, de Graaf J, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U. Castle JC, et al. Among authors: paret c. Sci Rep. 2014 Apr 22;4:4743. doi: 10.1038/srep04743. Sci Rep. 2014. PMID: 24752137 Free PMC article.
Exploiting the mutanome for tumor vaccination.
Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, Koslowski M, Kuhn AN, Britten CM, Huber C, Türeci O, Sahin U. Castle JC, et al. Among authors: paret c. Cancer Res. 2012 Mar 1;72(5):1081-91. doi: 10.1158/0008-5472.CAN-11-3722. Epub 2012 Jan 11. Cancer Res. 2012. PMID: 22237626 Free article.
Confidence-based somatic mutation evaluation and prioritization.
Löwer M, Renard BY, de Graaf J, Wagner M, Paret C, Kneip C, Türeci O, Diken M, Britten C, Kreiter S, Koslowski M, Castle JC, Sahin U. Löwer M, et al. Among authors: paret c. PLoS Comput Biol. 2012;8(9):e1002714. doi: 10.1371/journal.pcbi.1002714. Epub 2012 Sep 27. PLoS Comput Biol. 2012. PMID: 23028300 Free PMC article.
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.
Castle JC, Loewer M, Boegel S, de Graaf J, Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U. Castle JC, et al. Among authors: paret c. BMC Genomics. 2014 Mar 13;15(1):190. doi: 10.1186/1471-2164-15-190. BMC Genomics. 2014. PMID: 24621249 Free PMC article.
CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer.
Paret C, Simon P, Vormbrock K, Bender C, Kölsch A, Breitkreuz A, Yildiz Ö, Omokoko T, Hubich-Rau S, Hartmann C, Häcker S, Wagner M, Roldan DB, Selmi A, Türeci Ö, Sahin U. Paret C, et al. Oncotarget. 2015 Sep 22;6(28):25356-67. doi: 10.18632/oncotarget.4516. Oncotarget. 2015. PMID: 26327325 Free PMC article.
PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation.
Roldán DB, Grimmler M, Hartmann C, Hubich-Rau S, Beißert T, Paret C, Cagna G, Rohde C, Wöll S, Koslowski M, Türeci Ö, Sahin U. Roldán DB, et al. Among authors: paret c. Oncotarget. 2020 May 19;11(20):1862-1875. doi: 10.18632/oncotarget.27582. eCollection 2020 May 19. Oncotarget. 2020. PMID: 32499871 Free PMC article.
86 results